These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 36387071)

  • 1. Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer.
    Jungles KM; Holcomb EA; Pearson AN; Jungles KR; Bishop CR; Pierce LJ; Green MD; Speers CW
    Front Oncol; 2022; 12():1022542. PubMed ID: 36387071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Radiation Therapy and Immune Checkpoint Blockade Therapy for Breast Cancer.
    Hu ZI; Ho AY; McArthur HL
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):153-164. PubMed ID: 28816141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy?
    Heidegger I; Necchi A; Pircher A; Tsaur I; Marra G; Kasivisvanathan V; Kretschmer A; Mathieu R; Ceci F; van den Bergh RCN; Thibault C; Tilki D; Valerio M; Surcel C; Gandaglia G;
    Eur Urol Oncol; 2021 Oct; 4(5):745-754. PubMed ID: 33243663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Noninvasive Imaging to Combined Immune Checkpoint Inhibitors for Breast Cancer: Facts and Future.
    Cheng Z; Du Y; Yu L; Yuan Z; Tian J
    Mol Imaging Biol; 2022 Apr; 24(2):264-279. PubMed ID: 35102468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Checkpoint Inhibitor with or without Radiotherapy in Melanoma Patients with Brain Metastases: A Systematic Review and Meta-Analysis.
    Kim PH; Suh CH; Kim HS; Kim KW; Kim DY; Lee EQ; Aizer AA; Guenette JP; Huang RY
    Korean J Radiol; 2021 Apr; 22(4):584-595. PubMed ID: 33289357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions.
    Wang Y; Deng W; Li N; Neri S; Sharma A; Jiang W; Lin SH
    Front Pharmacol; 2018; 9():185. PubMed ID: 29556198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current advances in immune checkpoint inhibitor combinations with radiation therapy or cryotherapy for breast cancer.
    Ho AY; Tabrizi S; Dunn SA; McArthur HL
    Breast Cancer Res Treat; 2022 Jan; 191(2):229-241. PubMed ID: 34714450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune checkpoint inhibitors: review of the existing evidence and challenges in breast cancer.
    Jalalvand M; Darbeheshti F; Rezaei N
    Immunotherapy; 2021 May; 13(7):587-603. PubMed ID: 33775102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Emergence of Immune-checkpoint Inhibitors in Colorectal Cancer Therapy.
    Ghidini M; Fusco N; Salati M; Khakoo S; Tomasello G; Petrelli F; Trapani D; Petrillo A
    Curr Drug Targets; 2021; 22(9):1021-1033. PubMed ID: 33563194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Immunotherapy Strategies in Breast Cancer.
    Yu LY; Tang J; Zhang CM; Zeng WJ; Yan H; Li MP; Chen XP
    Int J Environ Res Public Health; 2017 Jan; 14(1):. PubMed ID: 28085094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination Strategies of Checkpoint Immunotherapy in Metastatic Breast Cancer.
    Liu ZB; Zhang L; Bian J; Jian J
    Onco Targets Ther; 2020; 13():2657-2666. PubMed ID: 32308409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard therapies: solutions for improving therapeutic effects of immune checkpoint inhibitors on colorectal cancer.
    Liang T; Tong W; Ma S; Chang P
    Oncoimmunology; 2020 Jun; 9(1):1773205. PubMed ID: 32934878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting immune checkpoints in breast cancer: an update of early results.
    Solinas C; Gombos A; Latifyan S; Piccart-Gebhart M; Kok M; Buisseret L
    ESMO Open; 2017; 2(5):e000255. PubMed ID: 29177095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging drugs for the treatment of triple-negative breast cancer: a focus on phase II immunotherapy trials.
    Hall PE; Schmid P
    Expert Opin Emerg Drugs; 2021 Jun; 26(2):131-147. PubMed ID: 33870839
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors.
    Matsui JK; Perlow HK; Raj RK; Nalin AP; Lehrer EJ; Kotecha R; Trifiletti DM; McClelland S; Kendra K; Williams N; Owen DH; Presley CJ; Thomas EM; Beyer SJ; Blakaj DM; Ahluwalia MS; Raval RR; Palmer JD
    Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy in breast cancer: An overview of modern checkpoint blockade strategies and vaccines.
    Sanchez K; Page D; McArthur HL
    Curr Probl Cancer; 2016; 40(2-4):151-162. PubMed ID: 27855963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy Combined with Radiation Therapy in Breast Cancer: A Rapidly Evolving Landscape.
    Santa-Maria CA; Dunn SA; Ho AY
    Semin Radiat Oncol; 2022 Jul; 32(3):291-297. PubMed ID: 35688527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
    Esposito A; Criscitiello C; Curigliano G
    Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward innovative combinational immunotherapy: A systems biology perspective.
    Li XT; Yang JJ; Wu YL; Hou J
    Cancer Treat Rev; 2018 Jul; 68():1-8. PubMed ID: 29775845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing the efficacy of immunotherapy using radiotherapy.
    Keam S; Gill S; Ebert MA; Nowak AK; Cook AM
    Clin Transl Immunology; 2020; 9(9):e1169. PubMed ID: 32994997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.